Engineered hyaluronic acid-decorated niosomal nanoparticles for controlled and targeted delivery of epirubicin to treat breast cancer

Targeted drug delivery systems using nanocarriers offer a versatile platform for breast cancer treatment; however, a robust, CD44-targeted niosomal formulation has not been developed and deeply studied (both in vitro and in vivo) yet. Here, an optimized system of epirubicin (Epi)-loaded niosomal nan...

Descripción completa

Detalles Bibliográficos
Autores principales: Mansoori-Kermani, Amirreza, Khalighi, Sadaf, Akbarzadeh, Iman, Niavol, Fazeleh Ranjbar, Motasadizadeh, Hamidreza, Mahdieh, Athar, Jahed, Vahid, Abdinezhad, Masoud, Rahbariasr, Nikoo, Hosseini, Mahshid, Ahmadkhani, Nima, Panahi, Behnam, Fatahi, Yousef, Mozafari, Masoud, Kumar, Alan Prem, Mostafavi, Ebrahim
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Full Length Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304880/
https://www.ncbi.nlm.nih.gov/pubmed/35875198
http://dx.doi.org/10.1016/j.mtbio.2022.100349

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9304880/
https://www.ncbi.nlm.nih.gov/pubmed/35875198
http://dx.doi.org/10.1016/j.mtbio.2022.100349

Ejemplares similares